- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Durvalumab/Tremelimumab in neoadjuvant and Durvalumab in adjuvant setting
Total 562 results
-
Assistance Publique - Hôpitaux de ParisAstraZenecaRecruitingBCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFAFrance
-
Yonsei UniversityNational Cancer Center, Korea; Samsung Medical Center; AstraZeneca; Seoul National... and other collaboratorsUnknownOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingUrothelial CancerGermany, Switzerland
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
John L. Villano, MD, PhDActive, not recruitingTumor, SolidUnited States
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
Centre Georges Francois LeclercAstraZenecaCompletedColorectal Cancer MetastaticFrance
-
Seoul National University HospitalKorean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
University of Erlangen-Nürnberg Medical SchoolCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaGermany
-
University Hospital Inselspital, BerneAstraZenecaTerminatedMuscle-invasive Bladder CancerSwitzerland
-
University of NebraskaAstraZenecaTerminatedSmall Cell Lung CarcinomaUnited States
-
AstraZenecaCompleted
-
AstraZenecaActive, not recruitingPediatric Cancer | Hematological Malignancies | Solid Tumor PediatricSpain, Italy, United States, United Kingdom, France, Netherlands, Germany
-
Italian Network for Tumor Biotherapy FoundationAstraZenecaUnknownPeritoneal Mesothelioma | Pleural MesotheliomaItaly
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedMetastatic Anaplastic Thyroid CancerUnited States
-
Seoul National University HospitalCompletedDurvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLCKorea, Republic of
-
MedImmune LLCCompletedMyelodysplastic SyndromeUnited States, United Kingdom, France, Germany
-
AstraZenecaCompletedAdvanced Solid MalignanciesUnited States, Germany, Italy, United Kingdom, Canada, France, Korea, Republic of, Netherlands
-
Immunocore LtdAstraZenecaCompletedMalignant MelanomaUnited States
-
NSABP Foundation IncCompletedColorectal Cancer MetastaticUnited States
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca; European Organisation for Research and Treatment of Cancer - EORTC and other collaboratorsActive, not recruitingOral Cavity Squamous Cell CarcinomaBelgium
-
ARCAGY/ GINECO GROUPAstraZenecaActive, not recruiting
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
University of CologneAstraZenecaActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; MedImmune LLCCompletedMetastatic Colorectal CancerUnited States
-
AstraZenecaICON plcRecruitingHepatobiliary CancersUnited States, Puerto Rico, Germany, Italy, France, Greece
-
Wuhan Union Hospital, ChinaUnknownSmall Cell Lung Cancer | Anlotinib | Durvalumab
-
Nordic Society of Gynaecological Oncology - Clinical...European Network of Gynaecological Oncological Trial Groups (ENGOT); Gynecologic...Completed
-
MedImmune LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
Yonsei UniversityActive, not recruitingLarynx | Stage II-IVB Operable HNSCC Oral Cavity | Hypopharynx | OropharynxKorea, Republic of
-
MedImmune LLCCompletedDiffuse Large B-Cell LymphomaUnited States, France, United Kingdom, Ireland
-
Baylor College of MedicineCompletedMesotheliomaUnited States
-
Centre Georges Francois LeclercAstraZenecaActive, not recruiting
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, Brazil, France, Italy, Russian Federation, Spain, Vietnam, Korea, Republic of, China, Germany, Ukraine, Japan, Hong Kong, Taiwan, India, Thailand
-
AstraZenecaCompletedNon - Small Cell Lung Cancer NSCLCUnited States, France, Germany, Italy, United Kingdom, Belgium, Poland, Romania, Taiwan, Thailand, Canada, Korea, Republic of, Czechia, Hungary, Japan, Russian Federation, Hong Kong, Spain, Netherlands, Greece, Australia, Serbia, Bu... and more
-
Enrico De ToniRecruiting
-
Asan Medical CenterSeoul National University Bundang Hospital; Hallym University Medical CenterCompletedMetastatic Gastric CancerKorea, Republic of
-
M.D. Anderson Cancer CenterMedImmune LLCActive, not recruitingAdvanced and/or Metastatic SarcomaUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...AstraZenecaTerminated
-
AstraZenecaCompletedAdvanced Solid TumorsJapan, Korea, Republic of, Taiwan
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Spain, Canada, France, Korea, Republic of, Israel, Netherlands, United Kingdom
-
European Organisation for Research and Treatment...CompletedColorectal Cancer | Liver MetastasesFrance, Netherlands, Switzerland, Germany, Austria, Sweden
-
Tianjin Medical University Cancer Institute and...RecruitingUnrescetable Hepatocellular CarcinomaChina
-
Asan Medical CenterRecruitingResectable Gastric or Gastroesophageal Junction AdenocarcinomaKorea, Republic of
-
MedImmune LLCTerminatedAdvanced Solid Tumors | Aggressive B-cell LymphomasUnited States
-
AstraZenecaRecruiting
-
Gruppo Oncologico del Nord-OvestRecruitingGastric Cancer | Microsatellite InstabilityItaly